about
Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinomaMilk derived colloid as a novel drug delivery carrier for breast cancerCysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.Genome-wide and gene-specific epigenomic platforms for hepatocellular carcinoma biomarker development trials.Association between lifestyle factors and CpG island methylation in a cancer-free population.Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCRAn epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urineAssociation of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma.Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.Notch1 mutations are drivers of oral tumorigenesisGSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progressionCancer epigenetics: above and beyondDetection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes.An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation.Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNACorrelation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alterationEDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling.Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screeningTissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer.Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer.Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean populationAdenoid cystic carcinoma: emerging role of translocations and gene fusionsEpigenetic silencing of S100A2 in bladder and head and neck cancersEvaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitorsMutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.Comparative mutational landscape analysis of patient-derived tumour xenografts.MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patientsPromoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patientsCorrection: Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression.High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencing.Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
P50
Q28266809-05F0C190-9636-449C-AC23-940301A50984Q28392295-343EF00C-9806-4341-84A9-710FAEC3A549Q31101539-06807FDF-82E2-4ED5-B09E-381B37A95C67Q33562782-1E0428C3-2673-428E-B712-96E5E01B5896Q33886934-14BA8353-C115-4FC4-9C0F-260CD2CF7CECQ33917646-C309EAB9-1F2B-4641-BC54-BB0D2ABABB32Q33974374-7D06A958-D804-41AD-AA07-C42AEE622C8BQ34221765-8FBCC1AE-E971-4925-873D-9783BA9B0A8FQ35004607-14FA3754-B732-4E1C-A170-577C0C60C9BEQ35096197-F44DDAD7-CD69-4C4B-9C33-59430F391207Q35133434-A64A4F94-D664-40AB-888A-AA9E8C86D8EFQ35164353-66F5D780-442E-46BE-8C3A-3D9BA5E7D28DQ35251675-86907EA5-7415-41C9-8897-726595FD0C60Q35322421-0D13B29A-61BA-4206-B71E-9C82CC6808D9Q35636561-69A960CD-4FA7-4E75-A93A-243ADB4A3688Q35844494-A651899A-6CD3-44E5-A84F-47FA67BA7C18Q35859015-F02148AB-8A12-4753-9B39-1CFF4AC809C1Q36002695-3CA28FA6-6977-4042-98E2-94FF4C9D654EQ36128449-5D4F1C8A-B15A-40D0-B1AC-FE408C905BAFQ36149220-F10090A2-0F7D-45FA-A11E-4EF3A66C96D4Q36213122-D44C5450-2C19-4BD5-9AB3-EEBDC3060661Q36328291-E159330D-D1A7-4B3F-B822-C389037660D3Q36941462-1D9B6A92-F81F-43F1-97C9-710C34EAA649Q36953349-452DE84A-88E3-409A-84E0-B708B59B604AQ36992178-FB03A853-B2B7-4000-81DB-7352C17D66CAQ37173021-EE814B4E-D4B5-48D4-BF69-410963C383D4Q37424550-A081BA37-C87C-42B3-909E-BAF5D1F87361Q37655869-5D389535-4482-4FA9-A8DB-337720F642F1Q37662396-449D243C-2E5A-4E1A-9184-DF89E0AACDE7Q38424946-EA09F1DA-568A-47EA-82C9-D2015EA11474Q38502777-F737348A-0B7F-4E71-8796-1DE910423B61Q38994746-B48155B6-6F46-44E3-9E0A-27FD267FD418Q39670597-D3DE9461-A93A-4B44-9C0F-B1241F960723Q40366394-DDEA2A3F-F7FE-4343-9C92-B286620F7659Q41612255-FF976F89-0A98-48CE-A72F-90544ACD60C1Q42314696-51BA4C07-1EB7-4B0A-93F0-9DAD5914CB77Q46479064-7E5DB06D-70D2-471A-9EF0-33A5E951CEEFQ46633781-58D6BF45-CDBF-41A1-AFAC-511995981A11Q46704094-B0F56D2B-C603-49B0-B464-6B100BEA1F89Q47691502-5C30BE13-8B23-4BE7-B288-26620723840D
P50
description
onderzoeker
@nl
researcher ORCID id 0000-0002-1652-8921
@en
name
Mariana Brait
@ast
Mariana Brait
@en
Mariana Brait
@es
Mariana Brait
@nl
type
label
Mariana Brait
@ast
Mariana Brait
@en
Mariana Brait
@es
Mariana Brait
@nl
prefLabel
Mariana Brait
@ast
Mariana Brait
@en
Mariana Brait
@es
Mariana Brait
@nl
P106
P1153
14420816200
P21
P31
P496
0000-0002-1652-8921